The World Health Organization (WHO)-led Global Polio Laboratory Network (GPLN) continues to play an essential role in global polio eradication, and periodic efforts to quantify its overall value provide important information that helps to motivate financial support for GPLN laboratories. Assessing the value of the GPLN is of utmost importance at this stage of the GPEI, as the partners discuss the strategies to maintain polio laboratory functions pre- and post-certification of wild poliovirus eradication and global containment of live polioviruses. This GPLN survey aims to collect data on activities and costs of all of the GPLN laboratories to support an overall synthesis. The objectives of this survey include to: (1) update estimates of the total costs of the GPLN reported based on a similar 2003 survey, (2) better understand the different cost components, including environmental surveillance, and (3) characterize the extent to which the GPLN contributes to surveillance of other diseases.  The survey form should take approximately 60 minutes to complete, and we expect that collecting data and calculating some of the costs may take an additional 1-4 hours, depending on the size and complexity of the laboratory.  Please start the survey as soon as possible, so if you have any questions or if you need to compile data, you will have time to do so.  The survey includes questions about acute flaccid paralysis (AFP) surveillance (i.e., stool samples from AFP cases and contacts) and environmental surveillance (i.e., sewage samples). 
Please note:
·       we pre-filled some answers based on data collected in GPLNMS annual reports for 2016 as of June 2017, and we ask that you please check the pre-filled answers carefully and correct the information as appropriate.
·       please do not leave any answers blank, because we cannot interpret these correctly, so please enter “0” for zero, “unknown” for unknown, “not applicable” for not applicable, or “data not available” or other appropriate text.  If you find any question too difficult to answer, please do not quit the entire question or survey, but instead reply with “unable to answer” and please add any information that can help us understand the reason.
We provided a glossary to promote consistent interpretation of survey language.  If you have any questions, please contact Dr. Radboud Duintjer Tebbens (Kid Risk), at and Dr. Ousmane Diop (WHO),  Thank you very much for your time and effort to respond to the survey.  We look forward to hearing from you - please complete your response by September 1, 2017.  We will share the results with all polio laboratory directors for dissemination once they become available.

* 1. Please provide information about how to contact you and about your laboratory